121 related articles for article (PubMed ID: 6236800)
1. Cell-mediated immunity in the aetiopathogenesis of insulin-dependent (type I) diabetes mellitus.
Pozzilli P; Zuccarini O; Sensi M; Spencer KM; Bottazzo G
Biomed Biochim Acta; 1984; 43(5):621-5. PubMed ID: 6236800
[TBL] [Abstract][Full Text] [Related]
2. The thymus-dependent immune system in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus. Animal model and human studies.
Buschard K
Dan Med Bull; 1985 Jun; 32(3):139-51. PubMed ID: 3160550
[TBL] [Abstract][Full Text] [Related]
3. Characterization of immunoregulatory T lymphocytes in insulin-dependent diabetic children by means of monoclonal antibodies.
Mascart-Lemone F; Delespesse G; Dorchy H; Lemiere B; Servais G
Clin Exp Immunol; 1982 Feb; 47(2):296-300. PubMed ID: 6210472
[TBL] [Abstract][Full Text] [Related]
4. Relation between cellular and humoral immunity to islet cell antigens in type 1 diabetes.
Hummel M; Durinovic-Bello I; Ziegler AG
J Autoimmun; 1996 Jun; 9(3):427-30. PubMed ID: 8816982
[TBL] [Abstract][Full Text] [Related]
5. Alterations of peripheral T-lymphocyte subpopulations in patients with insulin-dependent (type 1) diabetes mellitus.
Buschard K; Röpke C; Madsbad S; Mehlsen J; Sørensen TB; Rygaard J
J Clin Lab Immunol; 1983 Mar; 10(3):127-31. PubMed ID: 6221108
[TBL] [Abstract][Full Text] [Related]
6. CD11B lymphocytes in type 1 diabetes mellitus of recent onset.
Bizzarro A; De Bellis A; Amoresano Paglionico V; Auletta M; Gattoni A; Altucci P; Iacono G
Horm Metab Res Suppl; 1992; 26():121-2. PubMed ID: 1490677
[TBL] [Abstract][Full Text] [Related]
7. Effects of thymosin and insulin on suppressor T cell in type 1 diabetes.
Wang SH; Chen G; Zhang K
Diabetes Res; 1992 Jan; 19(1):21-9. PubMed ID: 1468183
[TBL] [Abstract][Full Text] [Related]
8. [Cellular immunity in insulin-dependent diabetes mellitus (type 1)].
Korfel J; Kinalska I; Rogowski F; Citko A
Pol Tyg Lek; 1990 May 7-14; 45(19-20):373-5. PubMed ID: 2255653
[TBL] [Abstract][Full Text] [Related]
9. Deficiency of phenotypic cytotoxic-suppressor T lymphocytes in the BB/W rat.
Woda BA; Like AA; Padden C; McFadden ML
J Immunol; 1986 Feb; 136(3):856-9. PubMed ID: 2934480
[TBL] [Abstract][Full Text] [Related]
10. Immune islet killing mechanisms associated with insulin-dependent diabetes: in vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans.
Charles MA; Suzuki M; Waldeck N; Dodson LE; Slater L; Ong K; Kershnar A; Buckingham B; Golden M
J Immunol; 1983 Mar; 130(3):1189-94. PubMed ID: 6337213
[TBL] [Abstract][Full Text] [Related]
11. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes.
Narendran P; Williams AJ; Elsegood K; Leech NJ; Dayan CM
Diabetes Metab Res Rev; 2003; 19(1):52-9. PubMed ID: 12592644
[TBL] [Abstract][Full Text] [Related]
12. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
Goldrath AW; Barber L; Chen KE; Alters SE
J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
[TBL] [Abstract][Full Text] [Related]
13. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
[TBL] [Abstract][Full Text] [Related]
14. Cellular immune alterations associated with human insulin therapy.
Eichner HL; Lauritano AA; Woertz LL; Selam JL; Gupta S; Charles MA
Diabetes Res; 1988 Jul; 8(3):111-5. PubMed ID: 3067952
[TBL] [Abstract][Full Text] [Related]
15. Humoral and cellular immune abnormalities in neonates of diabetic mothers: any pathological role?
Dotta F; Gargiulo P; Tiberti C; Pachi A; Fallucca F; Andreani D; Di Mario U
Exp Clin Endocrinol; 1987 Aug; 89(3):333-9. PubMed ID: 3666051
[TBL] [Abstract][Full Text] [Related]
16. Prevention of autoimmune type I diabetes in biobreeding (BB) rats by a newly established, autoreactive T cell line from acutely diabetic BB rats.
Nagata M; Yoon JW
J Immunol; 1994 Oct; 153(8):3775-83. PubMed ID: 7930594
[TBL] [Abstract][Full Text] [Related]
17. Specific immunoregulation abnormality in insulin-dependent diabetes mellitus.
Fairchild RS; Kyner JL; Abdou NI
J Lab Clin Med; 1982 Feb; 99(2):175-86. PubMed ID: 6460826
[TBL] [Abstract][Full Text] [Related]
18. The frequency and immunodominance of islet-specific CD8+ T-cell responses change after type 1 diabetes diagnosis and treatment.
Martinuzzi E; Novelli G; Scotto M; Blancou P; Bach JM; Chaillous L; Bruno G; Chatenoud L; van Endert P; Mallone R
Diabetes; 2008 May; 57(5):1312-20. PubMed ID: 18305140
[TBL] [Abstract][Full Text] [Related]
19. Characterization of anti-islet cytotoxic human T-cell clones from patients with type 1 diabetes mellitus.
Sobel DO; Creswell K
Autoimmunity; 2006 Jun; 39(4):323-32. PubMed ID: 16891221
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes.
Endl J; Rosinger S; Schwarz B; Friedrich SO; Rothe G; Karges W; Schlosser M; Eiermann T; Schendel DJ; Boehm BO
Diabetes; 2006 Jan; 55(1):50-60. PubMed ID: 16380476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
